HOME
INDIA AT 2047
INDIA
WORLD
SPORTS
MOVIES
LIFESTYLE
TECHNOLOGY
SCIENCE
HEALTH
CRYPTO
MUTUAL FUNDS
PERSONAL FINANCE
OPINION
GAIL
IDEAS OF INDIA
UNCUT
WEB STORIES
EDUCATION
CRYPTO
BRAND WIRE
PODCAST
PHOTOS
GADGETS
WORLD
ELECTIONS
GAMING
AUTO
PIN CODE FINDER
LATEST MOBILE PHONES
IFSC CODE FINDER
CONTACT US
UTILITY
#
DRUGS CONTROLLER GENERAL OF INDIA
'Blood Is Not For Sale': DCGI's Big Move To Curb Overcharging By Hospitals, Blood Banks
'Himachal's Baddi Becoming 'Hub' Of Spurious Drugs': NHRC Notice To Health Ministry, DCGI And FSSAI
Licences Of 18 Pharma Firms Cancelled For Manufacturing Spurious Drugs: Report
Explained: As India Unveils SII's CERVAVAC, Know How Cervical Cancer Vaccines Work
Cervical Cancer Vaccine To Be Available In Few Months, To Be Priced Between Rs 200-400: Adar Poonawalla
SII To Launch India's First Indigenously Developed Vaccine Against Cervical Cancer Tomorrow
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
Tags:
Covid-19
SII
Covid-19 vaccine
Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report
Tags:
Coronavirus vaccine
Covid-19
Covid-19 vaccine
Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials
Tags:
Bharat Biotech
Covid vaccine
Covishield
Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
Tags:
Bharat Biotech
DCGI
Covishield
SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
Tags:
coronavirus
DCGI
Covid-19
Covaxin Showed Good Immune Response In Children, Slightly Better Than Adults: NTAGI Chief
Tags:
Bharat Biotech
covaxin
Drugs Controller General of India
Prev
1
Next